Viewing Study NCT06886659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2025-12-26 @ 6:34 AM
Study NCT ID: NCT06886659
Status: COMPLETED
Last Update Posted: 2025-07-22
First Post: 2025-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)
Sponsor: Incepta Pharmaceuticals Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Breast Neoplasms View
None Breast Disease View
None Antineoplastic Agents View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Biosimilarity View
None Bioequivalence View
None Tastuzumab View
None Healthy male volunteers View
None PK View